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a  b  s  t  r  a  c  t
-Adrenoceptor  (-AR)-mediated  relaxation  plays  an  important  role  in  the  regulation  of  vascular  tone.
-AR-mediated  vascular  relaxation  is reduced  in  various  disease  states  and aging.  We  hypothesized
that  -AR-mediated  vasodilatation  is  impaired  in DOCA-salt  hypertension  due  to  alterations  in the  cAMP
pathway.  -AR-mediated  relaxation  was  determined  in  small  mesenteric  arteries  from  DOCA-salt  hyper-
tensive and  control  uninephrectomized  (Uni)  rats. To  exclude  nitric  oxide  (NO)  and  cyclooxygenase  (COX)
pathways,  relaxation  responses  were  determined  in  the  presence  of l-NNA  and  indomethacin,  NO  syn-
thase inhibitor  and  COX  inhibitors,  respectively.  Isoprenaline  (ISO)-induced  relaxation  was  reduced  in
arteries  from  DOCA-salt  compared  to Uni  rats.  Protein  kinase  A (PKA)  inhibitors  (H89  or  Rp-cAMPS)  or
adenylyl  cyclase  inhibitor  (SQ22536)  did  not  abolish  the difference  in ISO-induced  relaxation  between
the  groups.  Forskolin  (adenylyl  cyclase  activator)-induced  relaxation  was  similar  between  the  groups.
The inhibition  of  IKCa/SKCa channels  (TRAM-34  plus  UCL1684)  or BKCa channels  (iberiotoxin)  reduced
ISO-induced  relaxation  only  in  Uni  rats  and  abolished  the  relaxation  differences  between  the  groups.  The
expression  of  SKCa channel  was  decreased  in DOCA-salt  arteries.  The  expression  of BKCa channel    subunit
was increased  whereas  the  expression  of  BKCa channel    subunit  was  decreased  in  DOCA-salt  arteries.
The  expression  of receptor  for activated  C  kinase  1  (RACK1),  which  is a binding  protein  for  BKCa channel
and  negatively  modulates  its  activity,  was  increased  in  DOCA-salt  arteries.  These results  suggest  that  the
impairment  of  -AR-mediated  relaxation  in  DOCA-salt  mesenteric  arteries  may  be  attributable  to  altered
IKCa/SKCa and/or  BKCa channels  activities  rather  than  cAMP/PKA  pathway.  Impaired  -AR-stimulated  BKCa
channel  activity  may  be due  to the  imbalance  between  its subunit  expressions  and  RACK1  upregulation.
© 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Vascular tone is generated through a net balance between
vasodilatation and vasoconstriction established via the effects of
a number of neurotransmitters and hormones [viz. epinephrine,
norepinephrine, angiotensin II, acetylcholine (ACh), nitric oxide
(NO), etc.] [1].  Elevated arterial blood pressure in most types of
hypertension is attributable to increased total peripheral resis-
tance, which results, at least in part, from alterations in humoral
and neurogenic components and in vascular endothelial and
smooth muscle functions [2,3]. Indeed, altered vascular tone,
which is a characteristic feature of human and various exper-
imental models of hypertension, has been associated not only
with impaired endothelium-dependent vasodilatation and reduced
endothelium-derived relaxing factors, including NO, prostacyclin
∗ Corresponding author. Tel.: +81 3 5498 5726; fax: +81 3 5498 5726.
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and endothelium-derived hyperpolarizing factor (EDHF) signal-
ing, but also with augmented vasoconstrictor signalings [4–9].
Growing evidence indicates that the activation of -adrenoceptors
(-ARs) modulates the peripheral vascular tone, thereby control-
ling the distribution of blood ﬂow to different tissues. In fact,
gene-targeting techniques that selectively inactivate -AR in mice
have demonstrated that these animals exhibit decreased vasodi-
latation, increased blood pressure, as well as increased pressure
responses induced by adrenaline infusion [10,11].
A number of different signaling pathways have been associ-
ated with -AR-mediated vasodilatation in blood vessels. It is
well recognized that the stimulation of -ARs in blood vessels
results in the activation of adenylyl cyclase (AC), which subse-
quently leads to the accumulation of intracellular cyclic adenosine
3′,5′-monophosphate (cAMP) and subsequent activation of cAMP-
dependent protein kinase A (PKA) [12]. Accordingly, relaxation of
vascular smooth muscle cells induced by the non-selective -AR
agonist isoprenaline (ISO) involves cAMP-dependent mechanisms
since the -AR subtypes are coupled to AC via Gs protein [13].
1043-6618/$ – see front matter ©  2012 Elsevier Ltd. All rights reserved.
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On the other hand, -AR-induced relaxations are not exclusively
triggered via cAMP-dependent mechanisms but also involve cAMP-
independent mechanisms [13–15].  Moreover, stimulation of -ARs
in blood vessels leads to hyperpolarization of smooth muscle cells
[16]. In smooth muscle and endothelium, K+ channels are consid-
ered crucial effector proteins in the regulation of vascular tone
and arterial blood pressure, and their activity is essential for the
setting of the negative membrane potential (i.e., hyperpolariza-
tion) [8,17–20]. The vascular smooth muscle and endothelial cells
express a variety of very diverse K+ channels covering all K+ chan-
nel gene subfamilies, such as ATP-sensitive K+ channels (KATP),
voltage-gated K+ channels (Kv), and Ca2+-activated K+ channel (KCa)
[8,17–20]. Previous reports suggested that -AR-induced vascu-
lar hyperpolarization is linked to the activation of KATP channels
[16,21]. Accordingly, vasorelaxant responses induced by activation
of both 1- and 2-AR involve the opening of KATP channels in
the rat perfused mesenteric bed [22]. Matsushita et al. [15] found
that, in rat abdominal aortic smooth muscle, 1-/2-AR-mediated
and cAMP-independent relaxant mechanisms are partly due to
activation of the large-conductance KCa (BKCa) channel, whereas
3-AR-mediated relaxation is attributed to Kv channel.
Several lines of evidence suggest that the activation of -ARs on
endothelial cells leads to the production/release of endothelium-
derived factors [23]. Over the last two decades, evidence has
accumulated that -AR activation contributes to vasodilatation
via stimulation of endothelial NO biosynthesis [24–27].  At least
in some vessels -AR-mediated NO production may  greatly out-
weigh any direct vasorelaxant effect of -AR located on vascular
smooth muscle cells [26]. Furthermore, the production of prosta-
cyclin by -AR stimulation has been described in rabbit coronary
endothelial cells [28]. Since complex interactions between different
vasodilator pathways in vascular smooth muscle have been pro-
posed for NO synthase (NOS) and cyclooxygenase (COX) [29,30],
it may  be difﬁcult to understand the relationship among -AR-
mediated relaxation, cAMP/PKA pathway and K+ channel activity
in hypertension. Although impairment of -AR-mediated vasodi-
latation has been described in both human and animal models of
hypertension [12,31–35],  no study has addressed the relaxation
effects of -AR-agonists in the absence of NOS- and COX-derived
products in small mesenteric arteries obtained from deoxycorti-
costerone acetate (DOCA)-salt rat, a model of arterial hypertension
[36–39].
Therefore, in the present study, we designed experiments
to investigate the mechanisms underlying the hypertension-
associated impairment of -AR-mediated dilatation in the rat small
mesenteric artery. We  hypothesized that -AR-mediated vasodi-
latation is impaired in DOCA-salt hypertension due to alterations in
cAMP pathway and/or KCa channel activity. Since complex interac-
tions between different vasodilator pathways in vascular smooth
muscle have been proposed for COX and NOS, we  performed all
functional experiments in the presence of indomethacin and NG-
Nitro-l-arginine (l-NNA), to inhibit COX and NOS, respectively.
Under these conditions, we determined whether cAMP/PKA path-
way or K+ channels might be responsible for the impairment of
-AR-mediated relaxation in arterial hypertension. We  also deter-
mined whether mesenteric arteries from control and hypertensive
rats exhibit differential expression of the BKCa channel subunits.
2. Materials and methods
2.1. Reagents
ACh, DOCA, phenylephrine (PE), indomethacin, UCL1684, 1-[(2-
chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34), forskolin
(FSK), isoprenaline hydrochloride (ISO), Rp-adenosine 3′,5′-cyclic
monophosphorothioate triethylammonium salt hydrate (Rp-
cAMPS), atenolol, glybenclamide and antibody against -actin
were all purchased from Sigma Chemical Co. (St. Louis, MO,
USA). SQ22536, H89 dihydrochloride, formoterol hemifumarate,
CL316243 disodium salt and iberiotoxin (IbTX) were obtained
from Tocris Bioscience (Ellisville, MO,  USA). 9,11-dideoxy-9,11-
methanoepoxy prostaglandin F2 (U46619) was from Cayman
Chemical (Ann Arbor, MI,  USA). NG-Nitro-l-arginine (l-NNA) was
obtained from Calbiochem (San Diego, CA, USA). Drugs were
dissolved in sterile HPLC grade water or dimethyl sulfoxide.
Indomethacin was dissolved ﬁrst in a small amount of 10−1 M
Na2CO3 solution and then made up to the ﬁnal volume with
HPLC grade water. The antibody against BKCa channel 1 subunit
was obtained from Abcam (Cambridge, MA,  USA). The antibod-
ies against SK3 and BKCa channel  subunit were obtained from
Alomone Labs (Jerusalem, Israel). The antibody against receptor for
activated C kinase 1 (RACK1) was obtained from BD Biosciences
(San Jose, CA, USA). Horseradish peroxidase-linked secondary
anti-mouse and anti-rabbit antibodies were obtained from GE
Healthcare (Piscataway, NJ, USA).
2.2. Animals and experimental design
Male Wistar rats (8 weeks old, 250–340 g; Harlan Laboratories,
Indianapolis, IN, USA) were used in this study. All procedures were
performed in accordance with the Guiding Principles in the Care
and Use of Animals and approved by the Georgia Health Sciences
University Committee on the Use of Animals in Research and Edu-
cation. The animals were housed two  or three per cage on a 12-h
light/dark cycle and fed a standard chow diet with water ad libitum.
DOCA-salt hypertension was induced in rats as previously
reported [36–39].  Brieﬂy, all animals were uninephrectomized
under anesthesia and were given no further treatment (control
Uni group) or received 1% NaCl plus 0.2% KCl in the drinking water
and DOCA silastic pellets (0.2 g/kg), which were implanted subcu-
taneously in the scapular region (DOCA-salt group). The duration
of treatment was 4–5 weeks.
One week before euthanasia, systolic blood pressure was mea-
sured by the tail-cuff method using a CODA system (Kent Scientiﬁc
Corporation). At the end of 4–5 weeks of treatment, second-order
mesenteric artery was isolated and submitted to experimental pro-
cedures.
2.3. Vascular functional study
Arterial isometric force was  recorded as previously described
[37]. After euthanasia, the mesentery was  rapidly isolated
and placed in an ice-cold physiologic salt solution (PSS)
containing: 130.0 mmol/L NaCl, 4.7 mmol/L KCl, 14.9 mmol/L
NaHCO3, 5.5 mmol/L glucose, 1.18 mmol/L KH2PO4, 1.17 mmol/L
MgSO4·7H2O, 1.6 mmol/L CaCl2·2H2O, and 0.026 mmol/L ethylene-
diaminetetraacetic acid. Second-order branches of mesenteric
artery were carefully cleaned of fat and connective tissue under
a stereomicroscope. The mesenteric arteries were then cut into
2 mm rings (internal diameter ≈150–250 m) (several rings
were obtained from each animal) and mounted on an isometric
Mulvany–Halpern myograph (Danish MyoTech; Aarhus, Denmark)
ﬁlled with 5 mL  PSS and continuously gassed with 95% O2–5% CO2
at 37 ◦C and recorded by a PowerLab 8/SP data acquisition system
(ADInstruments). The rings were stretched until an optimal rest-
ing tension, which was  established from preliminary length-active
tension curves, of 2.0 mN [37,40], and then allowed to equilibrate
for at least 45 min. Arterial integrity was assessed by contracting
the segments with a depolarizing concentration of 120 mM potas-
sium chloride (KCl) and subsequently, with PE (10−5 M) followed
by relaxation with ACh (10−5 M).
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Fig. 1. -Adrenoceptor-mediated relaxation, under nitric oxide synthase and cyclooxygenase inhibition, is impaired in DOCA-salt small mesenteric arteries.
Concentration–response curves for isoprenaline (ISO) (A), formoterol (B), CL316243 (C) and ISO in the presence of 10−5 M atenolol (D) in mesenteric arteries from DOCA-salt
hypertensive, and control Uni rats. All concentration–response curves were performed in the presence of 10−4 M l-NNA and 10−5 M indomethacin. Details are given under
Section  2. Data are means ± SEM. Number of determinations is shown within parentheses. *P < 0.05, DOCA-salt vs. Uni group. #P < 0.05, Uni vs. Uni atenolol group. †P < 0.05,
DOCA-salt vs. DOCA-salt atenolol group. ‡P < 0.05, Uni atenolol vs. DOCA-salt atenolol group.
After being washed, for all relaxation studies, the rings were
equilibrated for 30 min  in the combined presence of 10−4 M l-
NNA (NOS inhibitor) and 10−5 M indomethacin (COX inhibitor)
before the administration of the thromboxane analog (U46619,
3 ×10−7 M).  Cumulative concentration–response curves to ISO
(10−9–10−5 or 10−4 M),  a classical nonselective -AR agonist [41],
formoterol (10−9–10−5 M),  a selective 2-AR agonist [42] and
CL316243 (10−9–10−4 M),  a selective 3-AR agonist [41,43],  were
performed. To study the role of 1-AR in ISO-mediated relaxations
under NOS/COX inhibition, we performed concentration–response
curves to ISO in the presence of 10−5 M atenolol (selective
1-AR antagonist [42,44]). To study the role of cAMP/PKA path-
way in ISO-mediated relaxations under NOS/COX inhibition, ISO
responses were determined in the presence of 10−4 M SQ22536
(AC inhibitor [45]), 10−7 or 10−6 M H89 (PKA inhibitor [27,46]),
or 5 × 10−5 M Rp-cAMPS (PKA inhibitor [44]). To study the role
of KCa channels or KATP channels in ISO-mediated relaxations
under NOS/COX inhibition, responses to ISO were determined in
the presence of 10−5 M TRAM-34 [inhibitor of intermediate con-
ductance KCa (IKCa) [47–49]]  plus 10−7 M UCL1684 [inhibitor of
small conductance KCa (SKCa) [49,50]], 10−7 M IbTX (inhibitor of
BKCa [47,51]), or 10−6 M glibenclamide (inhibitor of KATP [16]).
These concentrations of inhibitors were chosen based on previous
studies.
2.4. Western blotting for SK3, BKCa subunits and RACK1
Mesenteric arteries from DOCA-salt and Uni groups were rapidly
isolated, cleaned from fat, dissected, and frozen in liquid N2. Pro-
teins [50 g (for SK3), 40 g (for  subunit of BKCa and RACK1)
or 20 g (for 1 subunit of BKCa)] extracted from the mesenteric
bed were separated by electrophoresis on a 10% polyacrylamide gel
and transferred to a nitrocellulose membrane. Nonspeciﬁc binding
sites were blocked with 5% skim milk in Tris-buffered saline solu-
tion with Tween (0.1%) for 1 h at room temperature. Membranes
were then incubated with antibodies overnight at 4 ◦C. Antibod-
ies were as follows: anti-SK3 (1:500; Alomone Labs), anti-BKCa
channel  subunit (1:500; Alomone Labs), anti-BKCa channel 1
subunit (1:1000; Abcam), anti-RACK1 (1:1000; BD Biosciences),
and -actin (1:15,000; Sigma). After incubation with secondary
antibodies, signals were revealed with chemiluminescence, visu-
alized by autoradiography, and quantiﬁed densitometrically.
Results were normalized by -actin expression and expressed
as a percentage of control. The -actin expression was  similar
between DOCA-salt and Uni groups in mesenteric arteries (data
not shown).
2.5. Data analysis and statistics
Experimental values were calculated relative to the maximal
changes from the contraction produced by U46619 in each seg-
ment. Concentration–response curves were ﬁtted using a nonlinear
interactive ﬁtting program (Graph Pad Prism 5.0; GraphPad Soft-
ware Inc., San Diego, CA, USA). Data are expressed as means ± SEM.
Statistical analysis of the concentration–response curves was
performed by using 2-way analysis of variance (ANOVA) for com-
parison between the groups. When compared to groups, data were
analyzed using ANOVA with post hoc Bonferroni test or Student’s t-
test. Western blot data were analyzed by 1-sample t test. The values
of P < 0.05 were considered statistically signiﬁcant.
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Fig. 2. cAMP/PKA pathway does not contribute to the impaired ISO-induced relaxation in DOCA-salt small mesenteric artery. The effect of cAMP/PKA pathway on ISO-induced
relaxation, under nitric oxide synthase and cyclooxygenase inhibition, in small mesenteric arteries from DOCA-salt and Uni rats. The effect of 10−4 M SQ22536 (A), 5 × 10−5 M
Rp-cAMPS (B), and 10−7 or 10−6 M H89 (C) on ISO-induced relaxation. (D) Concentration–response curves for forskolin (FSK) in mesenteric arteries from DOCA-salt and Uni
rats.  All concentration–response curves were performed in the presence of 10−4 M l-NNA and 10−5 M indomethacin. Details are given under Section 2. Data are means ± SEM.
Number  of determinations is shown within parentheses. *P < 0.05, DOCA-salt vs. Uni group. †P < 0.05, DOCA-salt SQ22536 (A), DOCA-salt Rp-cAMPS (B), or DOCA-salt 10−6 M
H89  (C) vs. Uni SQ22536 (A), Uni Rp-cAMPS (B), or Uni 10−6 M H89 (C), respectively.
3. Results
3.1. Body weight and systolic blood pressure of the rats
At 3 or 4 weeks after the surgery, the body weight of the DOCA-
salt rats was lower than that of control Uni rats (347.0 ± 11.9 g,
n = 24 vs. 421.3 ± 6.4 g, n = 28, P < 0.001; respectively). DOCA-salt
rats displayed higher systolic blood pressure in comparison with
Uni rats (181 ± 5 mm Hg, n = 24 vs. 130 ± 2 mm Hg, n = 28, P < 0.001;
respectively).
3.2. ˇ-AR agonist-induced relaxation was reduced in small
mesenteric arteries from DOCA-salt rats (under NOS and COX
inhibitions)
Since NO- and COX metabolites-mediated signaling adds fur-
ther complexity to the regulation of vascular tone, -AR-mediated
relaxation was determined under simultaneous inhibition of NO
production and prostaglandins (by 10−4 M l-NNA and 10−5 M
indomethacin, respectively). Under these conditions, ISO-induced
relaxation was greatly impaired in the DOCA-salt group compared
to the Uni group (Fig. 1A).
To investigate which -ARs are responsible for the impaired
response in mesenteric arteries from DOCA-salt rats, we examined
the relaxant effects of selective -AR agonists [2-AR selective ago-
nist (Fig. 1B) and 3-AR selective agonist (Fig. 1C)], and of ISO in
the presence of a selective 1-AR antagonist (Fig. 1D), in the pres-
ence of NOS/COX inhibitors. The 2-AR selective agonist formoterol
produced vasodilation, which was reduced in the DOCA-salt group
vs. Uni group (Fig. 1B). The 3-AR selective agonist CL316243 did
not cause vasodilation in mesenteric arteries from either the DOCA-
salt or Uni groups (Fig. 1C). The ISO-induced relaxation was  largely
blocked by the 1-AR antagonist atenolol in both groups (Fig. 1D).
It should be noted that in the presence of atenolol, ISO-induced
relaxation was  still reduced in the DOCA-salt vs. the Uni group
(Fig. 1D).
3.3. cAMP/PKA pathway does not contribute to the impaired
ISO-induced relaxation in DOCA-salt mesenteric artery
Several reports suggested that -AR-induced vasodilatation was
mediated by cAMP-dependent and -independent pathways [12,13].
To investigate a differential contribution of the cAMP/PKA pathway
in mesenteric arteries from DOCA-salt rats, we evaluated the effect
of cAMP/PKA pathway inhibitors on ISO-induced relaxation in the
presence of NOS/COX inhibitors (Fig. 2). Pretreatment of mesen-
teric arteries with an AC inhibitor [SQ22536 (10−4 M)]  slightly, but
not signiﬁcantly, reduced ISO-induced relaxations in both groups
(Fig. 2A). Rp-cAMPS (5 × 10−5 M),  which is a PKA inhibitor, did not
signiﬁcantly change ISO-induced relaxation in arteries from DOCA-
salt or Uni rats (Fig. 2B). H89, which is another PKA inhibitor, did
not affect (at 10−7 M)  or slightly reduced (at 10−6 M)  ISO relax-
ation in arteries from both groups (Fig. 2C). It should be noted
that these inhibitors did not abolish the difference in ISO-induced
relaxation between the groups (Fig. 2A–C). Moreover, the relax-
ation induced by forskolin, an AC activator, was similar between
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mesenteric arteries from the DOCA-salt and Uni groups (Fig. 2D).
These results suggested that the cAMP/PKA pathway does not
contribute to the impaired ISO-induced relaxation in mesenteric
arteries from DOCA-salt rats.
3.4. Contribution of KCa channels to ISO-mediated relaxation
In view of the published evidence that activation of KCa chan-
nels plays an important role in the regulation of -AR-mediated
relaxation and EDHF-mediated relaxation [13,14,18],  we exam-
ined the contribution of such channels to ISO-mediated relaxation,
in the presence of NOS/COX inhibition (Fig. 3). To examine a
role for the IKCa/SKCa channels, which are important for EDHF
actions [49–51],  rings were incubated with TRAM-34 (10−5 M)  and
UCL1684 (10−7 M),  inhibitors of IKCa and SKCa, respectively. ISO-
induced relaxation was markedly reduced by these treatments in
the Uni group, but not in the DOCA-salt group (Fig. 3A). Iberiotoxin
(10−7 M),  an inhibitor of BKCa channel markedly inhibited ISO-
induced relaxation in arteries from Uni rats, but not in DOCA-salt
arteries (Fig. 3B). Pretreatment of mesenteric arteries with a KATP
channel inhibitor [glibenclamide (10−6 M)]  slightly increased ISO-
induced relaxations in both groups (Fig. 3C). It should be noted that
treatments with KCa inhibitors (Fig. 3A and B), but not KATP inhibitor
(Fig. 3C), abolished the relaxation differences between the groups,
suggesting that IKCa/SKCa channels and BKCa channels, but not KATP
channel, greatly contribute to the defective of ISO-mediated relax-
ation in DOCA-salt mesenteric artery.
3.5. Expression of SKCa, BKCa channel subunits and RACK1 in
small mesenteric arteries
We  next examined the expressions of SK3 and BKCa channel
subunits in small mesenteric arteries by Western blotting analysis
(Fig. 4). Protein expression levels of SK3 were signiﬁcantly reduced
in mesenteric arteries of DOCA-salt rats compared with Uni rats
(Fig. 4A). BKCa channels are composed of pore-forming  and reg-
ulatory 1 subunits [52–54].  The expression of BKCa channel 
subunit was increased in the DOCA-salt group (vs. the Uni group)
(Fig. 4B), whereas the expression of BKCa channel 1 subunit was
reduced in the DOCA-salt group (vs. the Uni group) (Fig. 4C).
RACK1 is a seven-bladed-beta-propeller protein with seven
internal Trp-Asp 40 (WD40) repeats, and participates in cell signal-
ing by functioning as a scaffold protein [55]. RACK1 can bind BKCa
channel and is thought to impair its function [56]. Therefore, we
next investigated the expression of RACK1 protein in mesenteric
arteries from DOCA-salt and Uni rats (Fig. 5). Interestingly, the pro-
tein expression of RACK1 was signiﬁcantly increased in mesenteric
arteries from DOCA-salt rats vs. arteries from Uni rats (Fig. 5).
4. Discussion
Uncertainty still surrounds the role of vascular -ARs, and their
associated signaling, on vascular function. However, consistent
evidence provided by a number of studies shows an impaired
vasodilation in response to -ARs activation in several experimen-
tal models of hypertension [12,31–35].  The principal ﬁndings from
the present study, performed on small mesenteric arteries isolated
from DOCA-salt hypertensive and their normotensive (Uni) con-
trols, under NOS and COX inhibition, are: (1) -AR agonists-induced
vascular relaxations are reduced in the DOCA-salt group; (2) the
AC/cAMP/PKA pathway does not contribute to the impaired ISO-
induced vascular relaxation; (3) the inhibition of IKCa/SKCa channels
or BKCa channels suppresses ISO-induced relaxation in arteries
from controls, but not in arteries from the DOCA-salt group and
abolishes the differences in -AR-mediated relaxation between the
Uni and DOCA-salt groups; and (4) the inhibition of KATP channels
Fig. 3. KCa channels, but not KATP channels, contribute to impaired ISO-induced
relaxation in small mesenteric arteries from DOCA-salt rats. The effects of IKCa
(10−5 M TRAM-34) and SKCa (10−7 M UCL1684) channel inhibitors (A), BKCa channel
inhibitor (10−7 M IbTX) (B), and KATP channel inhibitor (10−6 M glibenclamide) (C)
on  ISO-induced relaxation, under inhibition of nitric oxide synthase and cyclooxy-
genase in small mesenteric arteries from DOCA-salt and Uni rats. Details are given
under Section 2. Data are means ± SEM. Number of determinations is shown within
parentheses. (A) *P < 0.05, DOCA-salt vs. Uni group. #P < 0.05, Uni vs. Uni TRAM-
34  UCL1684. (B) *P < 0.05, DOCA-salt vs. Uni group. #P < 0.05, Uni vs. Uni IbTX. (C)
*P < 0.05, DOCA-salt vs. Uni group. #P < 0.05, Uni vs. Uni glibenclamide. †P < 0.05,
DOCA-salt vs. DOCA-salt glibenclamide. ‡P < 0.05, DOCA-salt glibenclamide vs. Uni
glibenclamide group.
does not abolish the differences in ISO-induced relaxation between
the Uni and DOCA-salt groups. Moreover, a down-regulation of SKCa
channels, an imbalanced expression of BKCa subunits (viz. increased
 subunit and decreased 1 subunit), as well as an upregulation of
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Fig. 4. Altered expression of SK3 and BKCa channel subunits in small mesenteric arteries from DOCA-salt rats. Analysis of protein expression for SK3 (A) and pore forming 
(B)  and regulatory 1 (C) subunits of BKCa channel in mesenteric arteries from DOCA-salt and Uni rats. Upper:  Representative Western blots of SK3 or BKCa channel subunits.
Lower:  Bands were quantiﬁed as described in Section 2. Data are mean ± SEM of 4 (A) or 6 (B and C) determinations (SK3 or BKCa subunits/-actin). Number of determinations
is  shown within parentheses. *P < 0.05 vs. Uni group.
Fig. 5. Mesenteric artery from DOCA-salt hypertension rats exhibit increased expression of receptor for activated C-kinase 1 (RACK1). Western blots analysis for RACK1 in
mesenteric arteries from DOCA-salt and Uni rats. Left: Representative Western blots of RACK1. Right: Bands were quantiﬁed as described in Section 2. Ratios were calculated
for  the optical density of RACK1 over that of -actin. Data are mean ± SEM of 6 determinations. Number of determinations is shown within parentheses. *P < 0.05 vs. Uni
group.
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RACK1 protein expression are present in mesenteric arteries from
the DOCA-salt group.
There have been some controversial studies about the role of
endothelium-derived factors, such as NO and COX metabolites
on -AR-induced vascular relaxation. For instance, endothelium
denudation inhibited -AR-mediated relaxation in rat aorta [25],
pulmonary artery [57], mesenteric arteries [58] and dog coronary
artery [24], suggesting that endothelial NO and cyclic GMP  sys-
tem are involved. Indeed, NOS inhibition attenuated -AR-induced
relaxation in rat aorta [59], pulmonary artery [57], and mesen-
teric arteries [58]. However, there are others studies showing that
NOS inhibition or endothelium denudation failed to suppress -
AR-mediated relaxation [60]. Moreover, age-related differences in
-AR-mediated relaxation were associated with changes in COX
activity [61]. Therefore, in the present study, to exclude the effects
of NOS and COX signaling, we compared -AR-mediated relaxation
in small mesenteric arteries from DOCA-salt and Uni rats in the
presence of l-NNA and indomethacin.
At present, at least three populations of -AR subtypes have
been described to be involved in the -adrenergic responses in
blood vessels [43,62]. In various vessels, stimulation of 1-, 2-,
and 3-ARs leads to vasodilation. Briones et al. [41] have pro-
vided a very comprehensive study of -AR relaxation in the small
mesenteric arteries, using a range of agonists and antagonists and
direct visualization of the receptors. -ARs are mainly, but not
exclusively located to the smooth muscle layers, and the ago-
nist/antagonist proﬁle suggests that vasodilation is due to the
activation of 1-ARs. In the present study, we found that (1)
non-selective -AR agonist ISO-induced relaxation was smaller in
DOCA-salt rats than in control rats; (2) selective 2-AR agonist-
induced relaxation was  also smaller in DOCA-salt rats than in
control rats; (3) selective 3-AR agonist failed to cause vasodila-
tion in both groups; (4) ISO-induced relaxation was largely blocked
by the selective 1-AR antagonist atenolol; and (5) atenolol-
resistant ISO-induced relaxation was still smaller in arteries from
DOCA-salt rats vs. control rats. These results suggest that the acti-
vation of 1- and 2-, but not 3-AR induces vasodilation in small
mesenteric arteries under NOS/COX inhibition, and 1- and/or 2-
AR-activated signaling is impaired in small mesenteric arteries
from DOCA-salt rats.
Generally, the activation of -ARs leads to Gs/AC/cAMP/PKA
activation [12]. On the other hand, cAMP-independent pathways
are also involved in -AR-induced relaxation in various vessels
[13–15]. To address the association between the cAMP pathway and
-AR-induced relaxation, we used a pharmacological approach. In
the present study, we found that the difference of ISO-induced
relaxation between the DOCA-salt and Uni groups was  not abol-
ished by treatment with AC inhibitor (Fig. 2A) or PKA inhibitors
(Fig. 2B and C). These results suggest that cAMP-independent sig-
naling may  be responsible for the impaired ISO-induced vascular
relaxation in DOCA-salt rats. Further support for this hypothesis is
provided by the observations that the AC activator FSK produced
similar relaxation in small mesenteric arteries from the DOCA-salt
and Uni groups.
There is an emerging body of evidence suggesting that K+ chan-
nels play an important role in the control vascular tone and the
-AR-mediated response [8,14,17–20]. The three subtypes of KCa
channels [i.e., SKCa, IKCa, and BKCa channels] are present in the
vascular wall [18] and in healthy arteries, SKCa/IKCa channels are
preferentially located in endothelial cells, while BKCa channels
are preferentially expressed in vascular smooth muscle cells [18].
Moreover, the activation of SKCa/IKCa channels on endothelial cells
plays an important role as a source of EDHF signaling [8,18,49–51].
Indeed, -AR-induced hyperpolarization in vessels has been linked
to the activation of KATP channels [16], and vasorelaxant response
to both 1- and 2-AR activation involves the opening of KATP
channels in the rat perfused mesenteric bed [22]. Matsushita et al.
[15] found that in the rat abdominal aortic smooth muscle 1-/2-
AR-mediated and cAMP-independent relaxant mechanisms were
partly due to the BKCa channel. Therefore, we  have examined the
relative contributions of KATP, IKCa/SKCa, and BKCa to ISO-mediated
responses in DOCA-salt small mesenteric arteries, under conditions
of preserved EDHF signaling (i.e., under NOS/COX inhibition). In the
present study, the combined treatment with IKCa/SKCa inhibitors
(Fig. 3A) and treatment with BKCa channel inhibitor (Fig. 3B) abol-
ished the differences in ISO-induced relaxation between Uni and
DOCA-salt groups. In contrast, the treatment with a KATP channel
inhibitor did not abolish such differences (Fig. 3C). These results
strongly suggest that defective IKCa/SKCa and/or BKCa channel activ-
ity is responsible for the impaired ISO-induced relaxation in the
small mesenteric arteries from DOCA-salt rats. In agreement with
our functional data, a differential expression of SKCa and BKCa chan-
nels was  observed between the groups. Small mesenteric arteries
from DOCA-salt rats, when compared with arteries from Uni rats,
exhibited decreased levels of SKCa channel.
BKCa channels are expressed largely in vascular smooth muscle,
where they function as negative-feedback regulators of vascular
tone [18–20].  BKCa channels are composed of pore-forming  and
regulatory 1 subunits [18–20,52–54]. Upregulation of BKCa chan-
nel  subunit expression and function occurs in vascular smooth
muscle from aldosterone-salt hypertensive rats and SHR [63,64].
In the present study, the imbalanced expression of BKCa channel
subunits, such as increased  subunit (in agreement with a previ-
ous report [65]) and decreased 1 subunit were observed in small
mesenteric arteries from DOCA-salt hypertensive rats. The activ-
ity of the BKCa channel is regulated not only by expression of its
subunits, but also by various messengers including calcium, het-
erotrimeric GTP binding proteins, protein phosphatase, and protein
kinases [20,66–68].  Moreover, RACK1, which is a 7-sided propeller
protein with 7WD40 repeats that participates in cell signaling by
functioning as a scaffold protein [55], binds to BKCa channels in rat
basilar and pulmonary artery smooth muscle cells, a process that is
thought to impair BKCa channel function [56]. In the present study,
the expression of RACK1 protein was  increased in mesenteric arter-
ies from DOCA-salt hypertensive rats. Although the mechanisms by
which RACK1 interacts with the G protein-coupled receptor -AR
and BKCa channel subunits remain unclear at present, the reduction
of -AR-stimulated BKCa activation in DOCA-salt mesenteric arter-
ies might be attributable to the imbalanced expression of the BKCa
channels subunits and the increased RACK1 protein expression.
Further studies will be required to determine the molecular mech-
anisms of BKCa channel activation induced by -AR stimulation in
small mesenteric arteries.
5. Conclusions
In summary, the present results suggest that a defective -
AR-mediated relaxation in small mesenteric arteries is seen in
DOCA-salt hypertensive rats, under NOS and COX inhibition. Such
impaired responses may  be attributable to impairment in KCa chan-
nels, which results from down-regulation of SKCa channels and an
imbalance in the expression of the BKCa subunits. Therefore, KCa
channels may  represent new targets for the treatment of arterial
hypertension-associated vascular dysfunction. Additional studies
addressing the molecular mechanisms that regulate IKCa, SKCa, and
BKCa will help to understand the interaction of -AR with this sys-
tem and their role on blood pressure regulation.
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